About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Texting to Improve Adherence in HIV+ With Bipolar Disorder

NCT02090634·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of California, San Diego

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Ability to provide informed consent
18 years or older at the time of enrollment
HIV-infected
DSM-IV diagnosis Bipolar Disorder
Taking at least one medication to treat HIV illness
Taking at least one medication to treat bipolar disorder
Indication of less than 100% adherence to antiretroviral (ART) medication
Willingness to use electronic monitoring caps to track ART medication and BD medication
Willingness to respond to text messages

You may not be if

Axis I psychiatric diagnosis of psychotic spectrum disorder (e.g., schizophrenia)
Presence of a neurological condition (beyond HIV infection) known to impact cognitive functioning (e.g., Huntington's Disease, Stroke)
Unwillingness or inability to use electronic medication monitoring technology
Unwillingness or inability to use daily texting

The record

StatusCompleted

PhaseNo phase

Taking part58

StartedApr 2010

UpdatedAug 27, 2021

Conditions

HIV Disease Bipolar Disorder

Where1

HIV Neurobehavioral Research Program (HNRP), Department of Psychiatry, Univeristy of California
San Diego, California, United States

Clareo Health | Texting to Improve Adherence in HIV+ With Bipolar Disorder